DBHL

CIK 0001918080

Micro Revenue $6M Assets $22M as of Oct 11, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Want to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.

8-K Filed Oct 2, 2026 · Period ending Oct 1, 2026

Summary not yet generated.

8-K Filed Aug 31, 2026 · Period ending Feb 23, 2026

Summary not yet generated.

Partner

Trade DBHL commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

10-Q Filed Aug 7, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 6, 2026 · Period ending Aug 6, 2026

Summary not yet generated.

8-K Filed Jul 27, 2026 · Period ending Jul 23, 2026

Summary not yet generated.

8-K Filed Jun 17, 2026 · Period ending Jun 16, 2026

Summary not yet generated.

10-Q Filed May 15, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

S-1/A Filed May 6, 2026 Critical

DBHL files S-1/A for resale of up to 58.5M shares by selling stockholders; company gets no proceeds

6 material changes detected. Sign up free to read the summary.

View report

Latest financial statements

From 10-Q filed Aug 7, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(in thousands, except share and per share data)

Description	Three months ended June 30, 2026	Three months ended June 30, 2025	Six months ended June 30, 2026	Six months ended June 30, 2025
Revenue	1,319	1,634	2,766	3,154
Cost of services (exclusive of depreciation shown separately below)	(612)	(756)	(1,293)	(1,418)
Gross profit	707	878	1,473	1,736
Operating expenses:
Selling, general and administrative expenses	2,746	2,215	5,586	3,208
Research and development	1,180	—	4,669	—
Depreciation and amortization expense	25	30	50	59
Total operating expenses	3,951	2,245	10,305	3,267
Loss from operations	(3,244)	(1,367)	(8,832)	(1,531)
Gain on insurance settlement	27	—	27	—
Other income	181	4	353	3
Net loss before income taxes	(3,036)	(1,363)	(8,452)	(1,528)
Provision for income taxes	—	—	—	1
Net loss	(3,036)	(1,363)	(8,452)	(1,529)
Other comprehensive income (loss):
Foreign currency translation adjustments	(15)	9	33	(40)
Total other comprehensive income (loss)	(15)	9	33	(40)
Other comprehensive loss	(3,051)	(1,354)	(8,419)	(1,569)
Net loss per common share basic and diluted	(0.05)	(0.03)	(0.15)	(0.04)
Weighted average common shares outstanding basic and diluted	57,660,684	42,151,949	57,684,662	41,447,903

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

Description	June 30, 2026 (Unaudited)	December 31, 2025
Assets
Current assets:
Cash	19,379	27,434
Accounts receivable, net of allowance for credit losses of $124 and $118, respectively	465	439
Contract assets	527	275
Other current assets	573	672
Total current assets	20,944	28,820
Property, plant and equipment, net	194	128
Intangible assets, net	33	73
Finance lease right-of-use assets	9	11
Operating lease right-of-use assets	209	269
Goodwill	182	182
Other non-current assets	79	140
Total assets	21,650	29,623
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	1,216	1,113
Accrued payroll	290	774
Contract liabilities	—	150
Finance lease liabilities, current	3	3
Operating lease liabilities, current	132	125
Other current liabilities	252	101
Total current liabilities	1,893	2,266
Finance lease liabilities, net of current portion	7	9
Operating lease liabilities, net of current portion	84	152
Total liabilities	1,984	2,427
Commitments and Contingencies (Note 16)
Stockholders’ Equity
Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 57,667,113 and 57,542,113 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	6	6
Additional paid-in capital	60,345	59,456
Accumulated deficit	(40,955)	(32,503)
Accumulated other comprehensive income	270	237
Total stockholders’ equity	19,666	27,196
Total liabilities and stockholders’ equity	21,650	29,623

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands, except share and per share data)

Description	Six months ended June 30, 2026	Six months ended June 30, 2025
Cash Flows from Operating Activities:
Net loss	(8,452)	(1,529)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	50	59
Interest expense	1	1
Stock based compensation	885	55
Gain on insurance settlement	(27)	—
Changes in operating assets and liabilities:
Accounts receivable	(32)	313
Allowance for credit losses	6	12
Contract assets	(252)	(57)
Other current assets	99	44
Other non current assets	61	—
Account payable	103	198
Contract liabilities	(150)	—
Accrued expenses	(484)	(125)
Other current liabilities	146	410
Operating lease right-of-use assets and lease liabilities	2	1
Net cash used in operating activities	(8,044)	(618)
Cash Flows from Investing Activities:
Purchases of property, plant and equipment	(74)	(31)
Proceeds from insurance on disposal of fixed asset	27	—
Net cash used in investing activities	(47)	(31)
Cash Flows from Financing Activities:
Payment of finance lease liability	(1)	(2)
Proceeds from exercise of stock options	4	394
Net cash provided by financing activities	3	392
Net change in cash and cash equivalents	(8,088)	(257)
Effect of exchange rate on cash and cash equivalents	33	(40)
Cash and cash equivalents:
Beginning of period	27,434	2,149
End of period	19,379	1,852
Supplemental schedule of non-cash investing and financing activities:

Amounts as printed on the EDGAR/iXBRL face — (in thousands, except share and per share data). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View all filings for DBHL on SEC EDGAR